Targeted immune modulators for rheumatoid arthritis: effectiveness & value : evidence report
- Collection:
- Health Policy and Services Research
- Contributor(s):
- Institute for Clinical and Economic Review, issuing body.
- Publication:
- Boston, MA : Institute for Clinical and Economic Review, March 10, 2017
- Language(s):
- English
- Format:
- Text
- Subject(s):
- Arthritis, Rheumatoid -- drug therapy Comparative Effectiveness Research Immunologic Factors -- therapeutic use Abatacept -- therapeutic use Adalimumab -- therapeutic use Certolizumab Pegol -- therapeutic use Cost-Benefit Analysis Etanercept -- therapeutic use Immunologic Factors -- adverse effects Immunologic Factors -- economics Immunotherapy Infliximab -- therapeutic use Interleukin-6 -- antagonists & inhibitors Protein Kinase Inhibitors -- therapeutic use Randomized Controlled Trials as Topic Rituximab -- therapeutic use Treatment Outcome Tumor Necrosis Factor-alpha -- antagonists & inhibitors Value-Based Purchasing Humans United States
- Genre(s):
- Technical Report
- Copyright:
- Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
- Extent:
- 1 online resource (1 PDF file (vii, ES28, 507 pages))
- Illustrations:
- Illustrations
- NLM Unique ID:
- 101704704 (See catalog record)
- Permanent Link:
- http://resource.nlm.nih.gov/101704704